C40B 30 - Methods of screening libraries

Patents for C40B 30 - Methods of screening libraries (11,320)
12/2011
12/22/2011	US20110312520 Methods and compositions for diagnosing conditions
12/22/2011	US20110312519 Genetic factors associated with inhibitor development in hemophilia a
12/22/2011	US20110312518 Microfluidic devices for measurement or detection involving cells or biomolecules
12/22/2011	US20110312517 Method for the in vitro diagnosis of stroke
12/22/2011	US20110312516 Diagnostic and prognostic use of human bladder cancer-associated micro rnas
12/22/2011	US20110312515 Identification of markers in lung and breast cancer
12/22/2011	US20110312514 Method For Determination And Quantification Of Radiation Or Genotoxin Exposure
12/22/2011	US20110312512 Culture system and method for immunogenicity and immunofunction testing in vitro
12/22/2011	US20110312511 Multiplex Detection of Tumour Cells Using a Panel of Agents Binding to Extracellular Markers
12/22/2011	US20110312510 High-Throughput Complement-Mediated Antibody-Dependent and Opsonic Bactericidal Assays
12/22/2011	US20110312509 Biomarkers downregulated in prostate cancer
12/22/2011	US20110312508 Physiogenomic method for predicting diabetes and metabolic syndromes induced by psychotropic drugs
12/22/2011	US20110312507 Reaction discovery system
12/22/2011	US20110312504 Methods, kits, and compositions for detection of mrsa
12/22/2011	US20110311585 Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity
12/22/2011	US20110311568 Vaccine
12/22/2011	US20110311511 CRYSTAL STRUCTURE OF PfA-M1 AND THE PfA-M1 Co4 COMPLEX
12/22/2011	US20110311450 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
12/22/2011	DE102008024282B4 Verfahren zur Vorhersage der Sekundärstruktur einer Nucleinsäuresequenz, Vorhersagevorrichtung für die Sekundärstruktur einer Nucleinsäuresequenz und Vorhersageprogramm zum Vorhersagen der Sekundärstruktur einer Nucleinsäuresequenz Method for predicting the secondary structure of a nucleic acid sequence predictor for secondary structure of nucleic acid sequence and prediction program for predicting the secondary structure of nucleic acid sequence
12/22/2011	CA2839846A1 Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
12/22/2011	CA2802953A1 Methods of generating and screening for lytic chimeric polypeptides
12/22/2011	CA2802868A1 Methods and systems for generating, validating and using monoclonal antibodies
12/21/2011	EP2397549A2 Non-stochastic generation of genetic vaccines and enzymes
12/21/2011	EP2397548A1 Methods of generating and screening for lytic chimeric polypeptides
12/21/2011	EP1360490B1 Nucleic-acid programmable protein arrays
12/15/2011	WO2011156529A2 Methods and composition for multiplex sequencing
12/15/2011	WO2011156387A2 Enumeration of nucleic acids
12/15/2011	WO2011132175A3 Novel biomarkers and targets for ovarian carcinoma
12/15/2011	US20110307964 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
12/15/2011	US20110306655 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/15/2011	US20110306570 Na/K-Atpase Expression as an Indicator for the Treatment of Cancer
12/15/2011	US20110306553 Methods and uses involving heme binding protein 1
12/15/2011	US20110306518 Methods and compositions for diagnosing and monitoring transplant rejection
12/15/2011	US20110306517 Reducing irf4, dusp22, or flj43663 polypeptide expression
12/15/2011	US20110306516 Methods for producing induced pluripotent stem cells
12/15/2011	US20110306515 DEVICE FOR SEROLOGICALLY DETECTING YERSINIA INFECTIONS AND/OR SECONDARY DISEASES THEREOF AND USE OF THE PROTEINS MyfA AND PsaA OF Y. ENTEROCOLITICA AND Y. PSEUDOTUBERCULOSIS AS RECOMBINANT ANTIGENS
12/15/2011	US20110306514 Ratio based biomarkers and methods of use thereof
12/15/2011	US20110306513 Novel biomarker for liver cancer and applications for same
12/15/2011	US20110306512 Gene Expression Profiling for Identification, Monitoring, and Treatment of Osteoarthritis
12/15/2011	US20110306511 Methods for multiplex analyte detection and quantification
12/15/2011	US20110306510 Optimized pprobes and primers and methods of using same for the detection, screening, isolating and sequencing of mrsa, mssa staphylococcus markers, and the antibiotic resistance gene mec a
12/15/2011	US20110306509 Compositions and methods for the identification of inhibitors of protein synthesis
12/15/2011	US20110306508 Method of Mycotoxin Detection
12/15/2011	US20110306507 Method and tools for prognosis of cancer in her2+partients
12/15/2011	US20110306506 Assay device and method for performing biological assays
12/15/2011	US20110306505 X-STR multiplex PCR amplification system
12/15/2011	US20110305703 Isolated vegf-c and vegf-d peptides and uses thereof
12/15/2011	US20110305677 Human embryonic stem cell cultures, and compositions and methods for growing same
12/15/2011	DE102008005062B4 Vorrichtung und Verfahren zum Bestimmen einer pharmazeutischen Aktivität eines Moleküls Apparatus and method for determining a pharmaceutical activity of a molecule
12/15/2011	CA2801564A1 Compositions and methods for protein production
12/15/2011	CA2801501A1 Pathways characterization of cells
12/15/2011	CA2801039A1 Enumeration of nucleic acids
12/14/2011	CN102282266A 高复杂度哺乳动物展示文库及其筛选方法 High complexity of mammalian display libraries and screening methods
12/13/2011	US8076467 Nucleic acid inhibitors of glutamate receptors
12/13/2011	US8076083 Screening methods involving the detection of short-lived proteins
12/08/2011	WO2011153308A2 In vitro method and apparatus for determining efficacy and action mechanisms of a topical composition on various skin color types
12/08/2011	WO2011150515A1 Prognostic markers for prostate cancer recurrence
12/08/2011	WO2011127150A3 Gene-expression profiling with reduced numbers of transcript measurements
12/08/2011	US20110301854 Method of Determining Allele-Specific Copy Number of a SNP
12/08/2011	US20110301221 Diagnosis, prognosis and treatment of glioblastoma multiforme
12/08/2011	US20110301095 Methods and compositions for assessing and treating metastasis, metastatic cancer, and potential for metastasis
12/08/2011	US20110301093 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/08/2011	US20110301063 Multiplexing derivatized anayltes using mass spectroscopy
12/08/2011	US20110301062 Reliable fluorescence correction method for two-color measurement fluorescence system
12/08/2011	US20110301061 High throughput experimentation methods for phase separation
12/08/2011	US20110301060 High throughput assays for transmissible spongiform encephalopathies (tse)
12/08/2011	US20110301059 Biomarkers For Human Papilloma Virus-Associated Cancers
12/08/2011	US20110301058 microfluidic device
12/08/2011	US20110301057 In situ oriented immobilization of proteins on a support
12/08/2011	US20110301056 Nectin-4 for target genes of cancer therapy and diagnosis
12/08/2011	US20110301055 Methods for determining a prognosis in multiple myeloma
12/08/2011	US20110301054 Method of Stratifying Breast Cancer Patients Based on Gene Expression
12/08/2011	US20110301053 Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
12/08/2011	US20110301052 Diagnostic evaluation of antibody responses to commonly recognized prostate cancer-associated antigens
12/08/2011	US20110301051 Biomarkers for Ulcerative Colitis and Crohn's Disease
12/08/2011	US20110301050 Dna hypermethylation brain cancer markers
12/08/2011	US20110301049 Fluid Flow Contour Control Using Flow Resistance
12/08/2011	US20110301048 Diagnosis and prognosis of breast cancer patients
12/08/2011	US20110301047 Sensing device for sensing a fluid
12/08/2011	US20110301046 Methods of Determining Efficacy of Glucocorticoid Treatment of Eosinophilic Esophagitis
12/08/2011	US20110301045 Composition and Methods Related to Modification of 5-Hydroxymethylcytosine (5-hmC)
12/08/2011	US20110300159 Sulfonated Sclerostin, antibodies, epitopes and methods for identification and use therefor
12/08/2011	US20110300152 Compositions and methods for modulating cell-cell fusion via intermediate-conductance calcium-activated potassium channels
12/08/2011	US20110300076 METHODS FOR PREPARATION OF ZnTe NANOCRYSTALS
12/08/2011	CA2801588A1 Gene expression signature as a predictor of chemotherapeutic response in breast cancer
12/08/2011	CA2801468A1 Prostate cancer associated circulating nucleic acid biomarkers
12/08/2011	CA2800281A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
12/08/2011	CA2799410A1 Prognostic markers for prostate cancer recurrence
12/07/2011	EP2391748A2 Li-kay hybrid peptides that modulate the immune response to influenza
12/07/2011	EP2391654A1 Urine and serum biomarkers associated with diabetic nephropathy
12/07/2011	EP2391653A1 Biomarkers associated with nephropathy
12/01/2011	WO2011150357A2 Methods and design of membrane filters
12/01/2011	WO2011149526A2 Methods and apparatuses for detection of positional freedom of particles in biological and chemical analyses and applications in immunodiagnostics
12/01/2011	WO2011147199A1 Compounds and methods for treating viral infections
12/01/2011	US20110296544 Colon cancer targets and uses thereof
12/01/2011	US20110294981 Chimeric t1r taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric t1r polypeptides
12/01/2011	US20110294700 High-throughput quantitation of crop seed proteins
12/01/2011	US20110294699 Methods and compositions for universal size-specific pcr
12/01/2011	US20110294698 Process for identifying drugs for treating gastroesophageal reflux
12/01/2011	US20110294697 System for detectng protease

1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 114